Epstein-Barr virus

TAK-659, an investigational compound being developed by Takeda Pharmaceuticals, is able to target lymphomas associated with Epstein-Barr virus (EBV) infection, preventing their growth and spread, a mouse study shows. ... Read more

A new type of T-cell-based cancer immunotherapy may offer hope to people with Epstein-Barr virus-positive Hodgkin’s lymphoma, a small clinical trial showed. Importantly, the therapy was designed for use ... Read more

Atara Biotherapeutics is conducting two Phase 3 clinical trials of a treatment for a transplant-related disorder that can include lymphoma. The company developed tabelecleucel (ATA129) for people whose dormant Epstein-Barr virus ... Read more

People infected with the Epstein-Barr virus have a higher chance of developing Hodgkin’s lymphoma, according to a new study, because a viral protein called BNRF1 leads to a faulty division ... Read more

The U.S. Department of Health and Human Services (HHS) has added seven new substances, including viruses that have been linked to lymphoma in humans, to the list of human carcinogens, which ... Read more

Lymphoma News Today

Disclaimer:

Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Pin It on Pinterest

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more